Moses Jennifer K. 4
4 · Viridian Therapeutics, Inc.\DE · Filed Jul 2, 2025
Insider Transaction Report
Form 4
Moses Jennifer K.
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-07-01+21,000→ 21,000 totalExercise: $14.47Exp: 2035-07-01→ Common Stock (21,000 underlying)
Footnotes (1)
- [F1]The option vests in full upon the earlier to occur of (i) July 1, 2026 or (ii) the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer.